The use of targeted radionuclide therapy for the treatment of malignant melanoma in vivo

Joyce, C. and Boyd, M. and Sorensen, A. and Tesson, M. and Babich, J. W. and Mairs, R. J. (2012) The use of targeted radionuclide therapy for the treatment of malignant melanoma in vivo. Mutagenesis, 27 (1). p. 110. ISSN 0267-8357

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

This study investigates the potential of the noradrenaline analogue [131I]MIBG (metaiodobenzylguanidine) and the novel melanin binding benzamide [131I] Solazed for melanoma therapy in vivo and in vitro.